| RSS
Business center
Office
Post trade leads
Post
Rank promotion
Ranking
 

US FDA and EMA Accept Applications for Ozanimod for the Treatment of Relapsing Forms of Multiple Scl Comments List

Positive
0% 0
/Neutral
0% 0
Negative
0% 0
Back to TOP
       Anonymous     (Enter between5to500characters)

                                 Current: 0words
 
 
Home | About | Service | copyright | agreement | contact | about | SiteMap | Links | GuestBook | Ads service | 京ICP 68975478-1
Tel:+86-10-68645975           Fax:+86-10-68645973
E-mail:yaoshang68@163.com     QQ:1483838028